Logo image of YJ

YUNJI INC-ADR (YJ) Stock Fundamental Analysis

NASDAQ:YJ - Nasdaq - US98873N3052 - ADR - Currency: USD

1.83  +0.01 (+0.55%)

Fundamental Rating

3

YJ gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 32 industry peers in the Broadline Retail industry. No worries on liquidiy or solvency for YJ as it has an excellent financial health rating, but there are worries on the profitability. YJ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

YJ had positive earnings in the past year.
YJ had negative earnings in 4 of the past 5 years.
In the past 5 years YJ always reported negative operating cash flow.
YJ Yearly Net Income VS EBIT VS OCF VS FCFYJ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -1B -2B

1.2 Ratios

Looking at the Return On Assets, with a value of -10.62%, YJ is doing worse than 87.10% of the companies in the same industry.
YJ's Return On Equity of -13.87% is on the low side compared to the rest of the industry. YJ is outperformed by 64.52% of its industry peers.
Industry RankSector Rank
ROA -10.62%
ROE -13.87%
ROIC N/A
ROA(3y)-4.1%
ROA(5y)-13.65%
ROE(3y)-5.04%
ROE(5y)-28.06%
ROIC(3y)N/A
ROIC(5y)N/A
YJ Yearly ROA, ROE, ROICYJ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -20K -40K -60K -80K

1.3 Margins

With a Gross Margin value of 31.24%, YJ is not doing good in the industry: 80.65% of the companies in the same industry are doing better.
YJ's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for YJ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.85%
GM growth 5Y28.8%
YJ Yearly Profit, Operating, Gross MarginsYJ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20 30

7

2. Health

2.1 Basic Checks

YJ does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for YJ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
YJ Yearly Shares OutstandingYJ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
YJ Yearly Total Debt VS Total AssetsYJ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

YJ has an Altman-Z score of -4.48. This is a bad value and indicates that YJ is not financially healthy and even has some risk of bankruptcy.
YJ has a worse Altman-Z score (-4.48) than 83.87% of its industry peers.
YJ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.48
ROIC/WACCN/A
WACC9.12%
YJ Yearly LT Debt VS Equity VS FCFYJ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B -1B

2.3 Liquidity

YJ has a Current Ratio of 2.30. This indicates that YJ is financially healthy and has no problem in meeting its short term obligations.
YJ's Current ratio of 2.30 is fine compared to the rest of the industry. YJ outperforms 77.42% of its industry peers.
YJ has a Quick Ratio of 2.18. This indicates that YJ is financially healthy and has no problem in meeting its short term obligations.
YJ has a better Quick ratio (2.18) than 90.32% of its industry peers.
Industry RankSector Rank
Current Ratio 2.3
Quick Ratio 2.18
YJ Yearly Current Assets VS Current LiabilitesYJ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

3

3. Growth

3.1 Past

YJ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 189.86%, which is quite impressive.
Looking at the last year, YJ shows a very negative growth in Revenue. The Revenue has decreased by -61.03% in the last year.
YJ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.91% yearly.
EPS 1Y (TTM)189.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-61.03%
Revenue growth 3Y-45.09%
Revenue growth 5Y10.91%
Sales Q2Q%-38.35%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
YJ Yearly Revenue VS EstimatesYJ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B
YJ Yearly EPS VS EstimatesYJ Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

2

4. Valuation

4.1 Price/Earnings Ratio

YJ is valuated cheaply with a Price/Earnings ratio of 0.39.
Based on the Price/Earnings ratio, YJ is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of YJ to the average of the S&P500 Index (29.63), we can say YJ is valued rather cheaply.
Industry RankSector Rank
PE 0.39
Fwd PE N/A
YJ Price Earnings VS Forward Price EarningsYJ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
YJ Per share dataYJ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for YJ!.
Industry RankSector Rank
Dividend Yield N/A

YUNJI INC-ADR

NASDAQ:YJ (2/21/2025, 8:00:02 PM)

1.83

+0.01 (+0.55%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)11-21 2024-11-21/bmo
Earnings (Next)03-19 2025-03-19
Inst Owners0.67%
Inst Owner Change-100%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap35.98M
Analysts37.78
Price TargetN/A
Short Float %31.29%
Short Ratio0.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.39
Fwd PE N/A
P/S 0.41
P/FCF N/A
P/OCF N/A
P/B 0.22
P/tB 0.22
EV/EBITDA N/A
EPS(TTM)4.67
EY255.19%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.49
BVpS8.34
TBVpS8.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.62%
ROE -13.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.24%
FCFM N/A
ROA(3y)-4.1%
ROA(5y)-13.65%
ROE(3y)-5.04%
ROE(5y)-28.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.85%
GM growth 5Y28.8%
F-ScoreN/A
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.3
Quick Ratio 2.18
Altman-Z -4.48
F-ScoreN/A
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)189.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-61.03%
Revenue growth 3Y-45.09%
Revenue growth 5Y10.91%
Sales Q2Q%-38.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A